|
|
| March 29, 2014: Dr. A. Michael Lincoff and Dr. C. Michael Gibson discuss: Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar |
Dr. A. Michael Lincoff and Dr. C. Michael Gibson discuss: Evaluation of the Dual
PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients
with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial.
TBD
[ Download video ] |
|
No comments have been submitted
|